{"organizations": [], "uuid": "5ae578b3ab8da3b77b6f6e161780f1bc90e6f2d0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180427.html", "section_title": "Archive News &amp; Video for Friday, 27 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-daiichi-sankyo-to-reorganize-kitas/brief-daiichi-sankyo-to-reorganize-kitasato-daiichi-sankyo-vaccine-into-specialized-manufacturing-unit-idUSL3N1S42UP", "country": "US", "domain_rank": 408, "title": "BRIEF-Daiichi Sankyo to reorganize Kitasato Daiichi Sankyo Vaccine into specialized manufacturing unit", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.027, "site_type": "news", "published": "2018-04-27T13:31:00.000+03:00", "replies_count": 0, "uuid": "5ae578b3ab8da3b77b6f6e161780f1bc90e6f2d0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-daiichi-sankyo-to-reorganize-kitas/brief-daiichi-sankyo-to-reorganize-kitasato-daiichi-sankyo-vaccine-into-specialized-manufacturing-unit-idUSL3N1S42UP", "ord_in_thread": 0, "title": "BRIEF-Daiichi Sankyo to reorganize Kitasato Daiichi Sankyo Vaccine into specialized manufacturing unit", "locations": [], "entities": {"persons": [{"name": "kitasato daiichi sanky", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "sankyo", "sentiment": "negative"}, {"name": "kitasato daiichi sankyo vaccine", "sentiment": "negative"}, {"name": "daiichi sankyo co ltd", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "vaccine co., ltd.", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 27 (Reuters) - Daiichi Sankyo Co Ltd\n* Says it plans to reorganize unit Kitasato Daiichi Sankyo Vaccine Co., Ltd. into a unit specializing in manufacturing, effective April 1, 2019\n* Says it will establish a Saitama-based wholly owned biotech unit in August\n* The manufacturing and production technology functions of Kitasato Daiichi Sankyo Vaccine will be transferred to the new unit on April 1, 2019\n* The functions of Kitasato Daiichi Sankyo Vaccine other than manufacturing and production technologies (research and development, quality assurance, sales and etc.) and marketing approvals will be transferred to the co\n* Other details will be disclosed later\nSource text in Japanese: goo.gl/HARj5T\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://goo.gl/HARj5T", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-27T13:31:00.000+03:00", "crawled": "2018-04-28T12:26:34.015+03:00", "highlightTitle": ""}